+0.7%
GSK vs BBAI
-54.4%
+55.2%
-13.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | BBAI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -7.7% | +7.4% | -0.5% |
| 7D | +0.2% | -14.0% | +14.2% | -0.1% |
| 30D | +5.4% | -12.4% | +17.8% | +5.4% |
| 3M | +0.9% | -42.8% | +43.7% | -0.8% |
| 6M | +0.7% | -54.6% | +55.4% | -2.1% |
| All | +0.7% | -54.4% | +55.2% | -2.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BBAI.
Daily Out/Under-Performance
Portfolio return minus BBAI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBAI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded BBAI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling